Leveraging the combination of oncolytic virotherapy and immune checkpoint blockade in soft tissue sarcoma (Supplemental) -- Steven Ian Robinson, MBBS

The Foundation's Harold Amos Medical Faculty Development Program was designed to provide four-year awards for postdoctoral research to clinician-scientists from historically underrepresented groups who are committed to developing careers in academia, improving the health of underserved populations, furthering scientific understanding, and eliminating health disparities.These supplemental funds to cohorts 2016 and 2017 of the Harold Amos Faculty Development Program will help scholars to complete their research that was impacted by COVID-19. The Scholar continued to fund his research assistant during the shutdown, and needs that assistance to complete his project. The project has changed and pivoted to focusing on a subtype of sarcoma. The in vivo nude mouse model work required to complete the project was also initially delayed with a halt on animal studies due to COVID.